Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Bio-Protocol
|
August 8, 2022
Whole-mount Senescence-Associated Beta-Galactosidase (SA-β-GAL) Activity Detection Protocol for Adult Zebrafish
Marta Marzullo, Mounir El Maï, Miguel Godinho Ferreira
Elife
|
May 20, 2020
Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish
Mounir El Maï, Marta Marzullo, Inês Pimenta de Castro, et al.
Molecular & Cellular Oncology
|
June 17, 2016
TRF2 acts as a transcriptional regulator in tumor angiogenesis
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, et al.
Cells
|
January 16, 2019
Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1
Kay-Dietrich Wagner, Mounir El Maï, Michael Ladomery, et al.
Epigenetics
|
December 23, 2014
Combined analysis of DNA methylation and cell cycle in cancer cells
Cécile Desjobert, Mounir El Maï, Tom Gérard-Hirne, et al.
Cancers
|
July 2, 2021
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
Mounir El Maï, Serena Janho Dit Hreich, Cedric Gaggioli, et al.
Nature Aging
|
May 4, 2023
Gut-specific telomerase expression counteracts systemic aging in telomerase-deficient zebrafish
Mounir El Maï, Malia Bird, Asma Allouche, et al.
Cell Reports
|
December 2, 2014
The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, et al.
Cell Reports
|
December 7, 2024
The absence of telomerase leads to immune response and tumor regression in zebrafish melanoma
Bruno Lopes-Bastos, Joana Nabais, Tânia Ferreira, et al.
Kidney International Reports
|
April 14, 2025
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
Maxime Teisseyre, Marco Allinovi, Vincent Audard, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Bio-Protocol
|
August 8, 2022
Whole-mount Senescence-Associated Beta-Galactosidase (SA-β-GAL) Activity Detection Protocol for Adult Zebrafish
Marta Marzullo, Mounir El Maï, Miguel Godinho Ferreira
Elife
|
May 20, 2020
Opposing p53 and mTOR/AKT promote an in vivo switch from apoptosis to senescence upon telomere shortening in zebrafish
Mounir El Maï, Marta Marzullo, Inês Pimenta de Castro, et al.
Molecular & Cellular Oncology
|
June 17, 2016
TRF2 acts as a transcriptional regulator in tumor angiogenesis
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, et al.
Cells
|
January 16, 2019
Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1
Kay-Dietrich Wagner, Mounir El Maï, Michael Ladomery, et al.
Epigenetics
|
December 23, 2014
Combined analysis of DNA methylation and cell cycle in cancer cells
Cécile Desjobert, Mounir El Maï, Tom Gérard-Hirne, et al.
Cancers
|
July 2, 2021
A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth
Mounir El Maï, Serena Janho Dit Hreich, Cedric Gaggioli, et al.
Nature Aging
|
May 4, 2023
Gut-specific telomerase expression counteracts systemic aging in telomerase-deficient zebrafish
Mounir El Maï, Malia Bird, Asma Allouche, et al.
Cell Reports
|
December 2, 2014
The Telomeric Protein TRF2 Regulates Angiogenesis by Binding and Activating the PDGFRβ Promoter
Mounir El Maï, Kay-Dietrich Wagner, Jean-François Michiels, et al.
Cell Reports
|
December 7, 2024
The absence of telomerase leads to immune response and tumor regression in zebrafish melanoma
Bruno Lopes-Bastos, Joana Nabais, Tânia Ferreira, et al.
Kidney International Reports
|
April 14, 2025
Obinutuzumab and Ofatumumab are More Effective Than Rituximab in the Treatment of Membranous Nephropathy Patients With Anti-Rituximab Antibodies
Maxime Teisseyre, Marco Allinovi, Vincent Audard, et al.
Page
of 1